Membrane microparticles mediate transfer of P-glycoprotein to drug sensitive cancer cells-Reference-Cited by-同舟云学术

Membrane microparticles mediate transfer of P-glycoprotein to drug sensitive cancer cells

Published:2009-04-16 Issue:9 Volume:23 Page:1643-1649
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Bebawy M,Combes V,Lee E,Jaiswal R,Gong J,Bonhoure A,Grau G E R

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu200976.pdf

Reference49 articles.

1. Roninson IB . Molecular mechanism of multidrug resistance in tumor cells. Clin Physiol Biochem 1987; 5: 140–151.

2. Horton JK, Houghton PJ, Houghton JA . Reciprocal cross-resistance in human rhabdomyosarcomas selected in vivo for primary resistance to vincristine and L-phenylalanine mustard. Cancer Res 1987; 47: 6288–6293.

3. Abd El-Ghaffar HA, Aladle DA, Farahat SE, Abd El-Hady N . P-glycoprotein (P-170) expression in acute leukemias. Hematology 2006; 11: 35–41.

4. Zhou SF . Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition. Xenobiotica 2008; 38: 802–832.

5. Ford JM . Experimental reversal of P-glycoprotein-mediated multidrug resistance by pharmacological chemosensitisers. Eur J Cancer 1996; 32A: 991–1001.

Cited by 278 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Intracellular and Extracellular Vesicles in the Development of Therapy Resistance in Cancer;Current Pharmaceutical Design;2024-10

2. Growth Hormone Upregulates Melanoma Drug Resistance and Migration via Melanoma-Derived Exosomes;Cancers;2024-07-24

3. Extracellular vesicles and cancer stem cells: a deadly duo in tumor progression;Oncology Reviews;2024-07-18

4. RNAs in tumour‐derived extracellular vesicles and their significance in the tumour microenvironment;International Journal of Cancer;2024-06-06

5. The Role of Tumor‐Derived Extracellular Vesicles in Drug Resistance in Urologic Cancers;Advanced Therapeutics;2024-05-25